GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (FRA:SH0) » Definitions » Accounts Payable & Accrued Expense

Shionogi (FRA:SH0) Accounts Payable & Accrued Expense : €219 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Shionogi Accounts Payable & Accrued Expense?

Shionogi's quarterly accounts payable & accrued expense declined from Sep. 2023 (€278 Mil) to Dec. 2023 (€168 Mil) but then increased from Dec. 2023 (€168 Mil) to Mar. 2024 (€219 Mil).

Shionogi's annual accounts payable & accrued expense increased from Mar. 2022 (€263 Mil) to Mar. 2023 (€393 Mil) but then declined from Mar. 2023 (€393 Mil) to Mar. 2024 (€219 Mil).

Shionogi Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shionogi's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Accounts Payable & Accrued Expense Chart

Shionogi Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 274.43 293.15 263.00 392.86 218.93

Shionogi Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 214.25 277.87 168.39 218.93 -

Shionogi Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shionogi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (FRA:SH0) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
TSE:4523 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 TSE:4534 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
SGIOY:USA SGIOF:USA 4507:Japan SH0:Germany
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
http://www.shionogi.co.jp
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi Headlines

No Headlines